FDA Delays Ruling on Generic Drug Safety Regulations
The New York Times reports that the Food and Drug Administration has delayed until 2017 a decision on whether or not to require the manufacturers of generic medications to warn patients of the potentially dangerous side-effects of their drugs. The argument made by the manufacturers of generic pharmaceuticals is that such labels would only confuse consumers
FDA Delays Ruling on Generic Drug Safety Regulations Read More »